Mangless Daniel John

Related Filers (2)

Other (1)

CORRESP
Wednesday, 3/15/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Show More

Ownership (5)

SC 13G
Thursday, 3/11/2021
Youngevity International, Inc.: Major Shareholders
SC 13G/A
Tuesday, 3/9/2021
KEMPHARM, INC: Major Shareholders
SC 13G
Friday, 3/13/2020
Youngevity International, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/11/2020
KEMPHARM, INC: Major Shareholders
SC 13G
Tuesday, 6/11/2019
KEMPHARM, INC: Major Shareholders
Show More

Proxies (4)

DEFC14A
Friday, 3/17/2023
Definitive proxy statement in connection with contested solicitations
PRRN14A
Thursday, 3/16/2023
Revised preliminary proxy statement filed by non-management
PREN14A
Friday, 3/3/2023
Preliminary proxy statement filed by non-management
DFAN14A
Friday, 3/3/2023
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
Show More